News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
278,472 Results
Type
Article (14513)
Company Profile (107)
Press Release (263844)
Multimedia
Podcasts (67)
Webinars (13)
Section
Business (89024)
Career Advice (503)
Deals (15534)
Drug Delivery (73)
Drug Development (37612)
Employer Resources (53)
FDA (6519)
Job Trends (6443)
News (152652)
Policy (14270)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (459)
Accelerated approval (13)
Adcomms (8)
Allergies (72)
Alliances (23480)
ALS (57)
Alzheimer's disease (506)
Antibody-drug conjugate (ADC) (114)
Approvals (6728)
Artificial intelligence (208)
Autoimmune disease (45)
Automation (12)
Bankruptcy (150)
Best Places to Work (4525)
BIOSECURE Act (9)
Biosimilars (121)
Biotechnology (40)
Bladder cancer (43)
Brain cancer (32)
Breast cancer (203)
Cancer (1508)
Cardiovascular disease (166)
Career advice (454)
Career pathing (27)
CAR-T (80)
CDC (7)
Cell therapy (192)
Cervical cancer (10)
Clinical research (32912)
Collaboration (744)
Compensation (328)
Complete response letters (34)
COVID-19 (790)
CRISPR (45)
C-suite (437)
Cystic fibrosis (63)
Data (2052)
Decentralized trials (1)
Denatured (18)
Depression (45)
Diabetes (139)
Diagnostics (1444)
Digital health (8)
Diversity (3)
Diversity, equity & inclusion (16)
Drug discovery (114)
Drug pricing (115)
Drug shortages (12)
Duchenne muscular dystrophy (82)
Earnings (33846)
Editorial (22)
Employer branding (4)
Employer resources (51)
Events (40192)
Executive appointments (530)
FDA (7674)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (450)
Gene editing (73)
Generative AI (18)
Gene therapy (173)
GLP-1 (466)
Government (1445)
Grass and pollen (4)
Guidances (166)
Healthcare (3690)
HIV (12)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (72)
Immuno-oncology (15)
Indications (54)
Infectious disease (854)
Inflammatory bowel disease (74)
Inflation Reduction Act (7)
Influenza (24)
Intellectual property (114)
Interviews (66)
IPO (6018)
IRA (33)
Job creations (2073)
Job search strategy (391)
JPM (28)
Kidney cancer (11)
Labor market (65)
Layoffs (230)
Leadership (13)
Legal (3467)
Liver cancer (25)
Longevity (8)
Lung cancer (210)
Lymphoma (175)
Machine learning (14)
Management (20)
Manufacturing (419)
MASH (68)
Medical device (1406)
Medtech (1413)
Mergers & acquisitions (9952)
Metabolic disorders (465)
Multiple sclerosis (48)
NASH (14)
Neurodegenerative disease (99)
Neuropsychiatric disorders (39)
Neuroscience (938)
Neurotech (1)
NextGen: Class of 2026 (1642)
Non-profit (627)
Now hiring (39)
Obesity (244)
Opinion (142)
Ovarian cancer (44)
Pain (111)
Pancreatic cancer (56)
Parkinson's disease (89)
Partnered (11)
Patents (223)
Patient recruitment (123)
Peanut (15)
People (29904)
Pharmaceutical (64)
Pharmacy benefit managers (18)
Phase 1 (8586)
Phase 2 (13908)
Phase 3 (12521)
Pipeline (1978)
Policy (139)
Postmarket research (1423)
Preclinical (3458)
Press Release (26)
Prostate cancer (91)
Psychedelics (16)
Radiopharmaceuticals (136)
Rare diseases (361)
Real estate (2679)
Recruiting (21)
Regulatory (11120)
Reports (20)
Research institute (589)
Resumes & cover letters (60)
Rett syndrome (5)
RNA editing (6)
RSV (20)
Schizophrenia (70)
Series A (80)
Series B (51)
Service/supplier (3)
Sickle cell disease (46)
Special edition (15)
Spinal muscular atrophy (84)
Sponsored (9)
Startups (1655)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (69)
The Weekly (47)
Vaccines (246)
Venture capital (38)
Weight loss (152)
Women's health (29)
Worklife (10)
Date
Last 7 days (180)
Last 30 days (718)
Last 365 days (10926)
2026 (976)
2025 (11247)
2024 (12954)
2023 (14684)
2022 (20014)
2021 (20459)
2020 (19407)
2019 (15161)
2018 (11940)
2017 (14132)
2016 (13338)
2015 (15736)
2014 (12563)
2013 (10669)
2012 (11475)
2011 (12009)
2010 (10961)
Location
Africa (321)
Alabama (19)
Alaska (1)
Arizona (78)
Arkansas (3)
Asia (21113)
Australia (2720)
California (3416)
Canada (1515)
China (581)
Colorado (150)
Connecticut (134)
Delaware (143)
Europe (41361)
Florida (611)
Georgia (69)
Hawaii (1)
Idaho (12)
Illinois (367)
India (45)
Indiana (244)
Iowa (3)
Japan (258)
Kansas (77)
Kentucky (20)
Louisiana (4)
Maine (2)
Maryland (434)
Massachusetts (2714)
Michigan (48)
Minnesota (169)
Mississippi (1)
Missouri (40)
Montana (8)
Nebraska (8)
Nevada (16)
New Hampshire (9)
New Jersey (1470)
New Mexico (7)
New York (951)
North Carolina (630)
North Dakota (2)
Northern California (1577)
Ohio (86)
Oklahoma (5)
Oregon (19)
Pennsylvania (734)
Puerto Rico (12)
Rhode Island (18)
South America (511)
South Carolina (11)
Southern California (1468)
Tennessee (54)
Texas (459)
United States (13274)
Utah (60)
Virginia (164)
Washington D.C. (44)
Washington State (232)
West Virginia (1)
Wisconsin (38)
Wyoming (1)
278,472 Results for "lb pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LB Pharmaceuticals Announces $100.0 Million Private Placement
February 5, 2026
·
5 min read
Press Releases
LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program
January 27, 2026
·
7 min read
Press Releases
LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel
January 21, 2026
·
5 min read
Press Releases
LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture
January 6, 2026
·
6 min read
Press Releases
LB Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices
December 10, 2025
·
5 min read
Press Releases
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
January 13, 2026
·
2 min read
IPO
UPDATE: Neuroscience Biotech LB Pulls Off Upsized $285M IPO
LB Pharma landed on the Nasdaq Thursday, with 3 million additional shares sold than expected.
September 11, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
LB Pharmaceuticals Announces Presentation at the Stifel 2025 Healthcare Conference
November 6, 2025
·
4 min read
Press Releases
LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer
November 13, 2025
·
5 min read
Press Releases
LB Pharmaceuticals Announces Presentation at the Piper Sandler 37th Annual Healthcare Conference
November 24, 2025
·
4 min read
1 of 27,848
Next
